Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1989
08/16/1989EP0327999A1 A pharmaceutical composition for relieving side effects of platinum-containing drugs
08/16/1989EP0327877A2 Peptide-renininhibitors
08/16/1989EP0327801A1 HIV-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
08/16/1989EP0327769A2 Novel neuronotrophic factor
08/16/1989EP0327756A2 Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer
08/16/1989EP0327744A1 Oxytocin and vasopressin antagonists
08/16/1989EP0327648A1 Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
08/16/1989EP0327640A1 Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome
08/16/1989EP0327633A1 Procedure for relieving cell mixtures and tissues of unwanted populations
08/16/1989EP0327612A1 Pharmaceutical therapeutic use of glutathione derivatives
08/15/1989US4857636 Stabilized tetramers
08/15/1989US4857635 Factor VIII coagulant polypeptides and monoclonal antibodies tof them
08/15/1989US4857520 Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation
08/15/1989US4857508 Novel platelet-aggregation inhibitor peptide derivatives
08/15/1989US4857507 Hypotensive agent
08/15/1989US4857506 Sustained release growth hormone compositions for parenteral administration and their use
08/15/1989US4857505 Sustained release compositions for parenteral administration and their use
08/15/1989US4857320 Method of enhancing the solubility of tissue plasminogen activator
08/15/1989US4857316 Synergistic antiviral composition
08/15/1989US4857315 Compositions containing golgi alpha-mannosidase II inhibitors
08/15/1989US4857314 C-reactive proteins in treatment of animal and human cancers
08/15/1989CA1258427A1 Process for the preparation of an aqueous insulin formulation which has been stabilized towards mechanical stresses, and its use
08/15/1989CA1258426A1 Synergistic mixtures of interferons and tumor necrosis-factor
08/10/1989WO1989007268A1 Monoclonal antibody specific to a novel mucin-like glycoprotein surface antigen on human carcinoma cells
08/10/1989WO1989007136A2 Modified hepatocytes and uses therefor
08/10/1989WO1989007113A1 Grf analogs
08/10/1989WO1989007111A1 Polypeptide compounds having growth hormone releasing activity
08/10/1989WO1989007110A1 Polypeptide compounds having growth hormone releasing activity
08/10/1989WO1989007109A1 Renin inhibiting peptides with polar end groups
08/10/1989WO1989007105A1 Staurosporin derivatives
08/10/1989WO1989006975A1 Method of reducing immunoglobulin e responses
08/10/1989WO1989006970A1 Lipid metabolism improving agent and method of its use
08/10/1989WO1989006969A1 Purified hemoglobin solutions and method for making same
08/10/1989WO1989006938A1 Device for surgical treatment of astigmatism
08/10/1989DE3803312A1 Use of an interferon-containing gel
08/10/1989DE3802895A1 Combination product for the treatment of disorders and injuries of nerve cells and nerve fibres
08/09/1989EP0327503A1 Use of IGF I in the manufacture of a medicament for the treatment of renal diseases
08/09/1989EP0327461A1 Use of milk proteins in making antiviral drugs
08/09/1989EP0327369A2 Human plalelet-derived growth factor receptor
08/09/1989EP0327360A2 Novel polypeptides and DNA encoding said polypeptides
08/09/1989EP0327334A2 Phospholipase A2-inhibiting peptides
08/09/1989EP0327283A1 Method of reducing immunoglobulin E responses
08/09/1989EP0327280A1 Cyclosporin compositions
08/09/1989EP0327259A2 Use of an agent for animal growth promotion
08/09/1989EP0327180A2 Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
08/09/1989EP0327169A2 Immunotoxins from barley toxin
08/09/1989EP0327045A1 The antibiotic cammunocine, process for its preparation and its use as a medicine
08/09/1989EP0327000A2 Gene fragments coding for the variable region of an anti-HIV antibody, chimeric anti-HIV antibodies expressed using the same, and process for their preparation
08/09/1989EP0326974A1 Amino acid amides with a psychotropic activity, processes for their preparation, compositions containing them and their use
08/09/1989EP0326907A1 Polypeptide, DNA and its use
08/09/1989EP0326873A2 Teicoplanin hydrazides
08/09/1989EP0326727A1 Sustained release implant and method for preparing same
08/09/1989EP0326595A1 Peptides and antibodies that inhibit platelet adhesion
08/08/1989US4855409 Novel polypeptides and method of producing same
08/08/1989US4855303 Fluorine containing renin inhibitors
08/08/1989US4855290 Derivatives of quinuclidine
08/08/1989US4855286 Renin-inhibiting di- and tripeptides, a process for their preparation, agents containing them, and their use
08/08/1989US4855284 Calcium and magnesium complexes of phytohemagglutinin-polyheteroglycans, their preparation and pharmaceutical formulations
08/08/1989US4855238 Recombinant gamma interferons having enhanced stability and methods therefor
08/08/1989US4855141 Device comprising means for protecting and dispensing fluid sensitive medicament
08/08/1989US4855134 Interferon in carriers
08/08/1989US4855090 Method of producing high aqueous volume multilamellar vesicles
08/08/1989CA1258230A1 Virus risk- reduced hemoglobin and method for making same
08/08/1989CA1258229A1 Amphipathic peptides
08/03/1989DE3901291A1 Compounds with psychotropic action, compositions containing these and the use thereof for the treatment and prophylaxis of central nervous system disorders
08/03/1989DE3801349A1 Circuit arrangement for measuring the supply voltage
08/02/1989EP0326490A2 Synthetic peptides and mixtures thereof for detecting HIV antibodies
08/02/1989EP0326418A1 GRF analogs
08/02/1989EP0326381A2 Use of 6RF in the diagnosis of M. Alzheimer
08/02/1989EP0326240A1 2-Amino acetamide derivatives
08/02/1989EP0326149A2 Adjuvant for cancer immunotherapy
08/02/1989EP0326148A1 Human monoclonal antibody specific for Pseudomonas aeruginosa and hybrid cell lines
08/02/1989EP0326120A2 Human IFN-beta2/IL-6, its purification and uses
08/02/1989EP0326075A2 Heparin-binding brain mitogens
08/02/1989EP0326067A2 Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
08/02/1989EP0326029A2 Antibiotic A 42867 derivative
08/02/1989EP0326014A1 Composition of anticoagulants
08/02/1989EP0326013A2 Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto
08/02/1989EP0325847A1 Method for the selection of anti-idiotype antibodies, and their use in the diagnosis, monitoring and treatment of disease
08/02/1989EP0325639A1 Fibrin-binding compound and method
08/02/1989EP0185715B1 Process for preparing antibiotic l 17392 (deglucoteicoplanin)
08/02/1989CN1034312A Method for preventing or treating anxiety employing ace inhibitor
08/01/1989US4853476 Phosphorus containing compounds as inhibitors of enkephalinases
08/01/1989US4853464 Hybridoma cell line XMMBR-B14 and monoclonal antibody which is specific for a non-cross reactive epitope of CEA
08/01/1989US4853371 Therapeutic somatostatin analogs
08/01/1989US4853370 Substitute for human blood and a method of making the same
08/01/1989US4853332 Encodes an interleukin or interferon; elimination of sites for intermolecular crosslinking or incorrect intramolicular disulfide bridging
08/01/1989US4853330 Human tissue plasminogen activator
08/01/1989US4853326 Oxidation of oligosaccharides with periodic acid
08/01/1989US4853226 Sustained-release particulate preparation and process for preparing the same
08/01/1989US4853220 Protein isolated from blood, process for preparing said protein, aantibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
08/01/1989US4853219 Angiogenesis inhibitors
08/01/1989US4853218 Zinc-protamine-alpha interferon complex
08/01/1989CA1258150A1 GONADOLIBERIN DERIVATIVES CONTAINING A .beta.-ASPARTYL GROUP, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
08/01/1989CA1258148A1 Process for the preparation of n-alkylated dipeptides and their esters
07/1989
07/27/1989WO1989006703A1 Diagnosis of retinoblastoma
07/27/1989WO1989006695A1 Cleaved dimers of mullerian inhibiting substance-like polypeptides
07/27/1989WO1989006692A1 Method of treating tumor cells by inhibiting growth factor receptor function
07/27/1989WO1989006690A1 Cloned genes encoding ig-cd4 fusion proteins and the use thereof
07/27/1989WO1989006657A1 Pulmonary surfactant protein and related polypeptide
1 ... 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 ... 3163